UnitedHealth Group, the nation’s largest private insurer, reported third-quarter results that surpassed Wall Street expectations and prompted the company to increase its full-year adjusted earnings outlook. The company raised its fiscal 2026 profit guidance to at least $20.50 per share, up from a previous range of $19.50 to $20 per share.
The company posted third-quarter net income of $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the year-earlier period. On an adjusted basis, excluding items such as business divestitures and restructuring costs, UnitedHealth earned $4.69 per share. Revenue declined to $112.69 billion from $113.16 billion a year earlier. Both the UnitedHealthcare insurer unit and the Optum healthcare division exceeded analyst operating earnings estimates for the quarter.
A key metric for profitability, the medical cost ratio, improved to 88.4% for the third quarter, better than analyst expectations of 89.9%. This ratio measures total medical expenses paid relative to premiums collected, with lower ratios indicating greater profitability. However, company leadership cautioned that medical costs remain elevated compared to historical levels, a persistent challenge for insurers managing privately run Medicare Advantage plans. The independent dispute resolution process established under the No Surprises Act is contributing at least 100 basis points to medical costs, while inpatient services and specialty pharmacy expenses remain elevated.
UnitedHealth attributed its improved financial performance to ongoing execution of its turnaround strategy, which includes membership reduction, exiting unprofitable contracts, and increased investment in value-based care and artificial intelligence. The company reported that acute hospital admissions among members declined 15% year over year through the third quarter while home health admissions increased 10%, reflecting a shift toward lower-cost care settings. The company is also deploying AI-powered tools to reduce administrative burden on physicians and noted that patient-initiated appointment scheduling rose 27% year over year. Management expects these initiatives to continue generating compounding benefits through the remainder of the year and into 2027.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI